Results

Total Results: 1,066 records

Showing results for "implications".

  1. effectivehealthcare.ahrq.gov/products/srdrplus
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  2. effectivehealthcare.ahrq.gov/products/insomnia/www.effectivehealthcare.ahrq.gov
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  3. effectivehealthcare.ahrq.gov/products/antipsychotics
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  4. effectivehealthcare.ahrq.gov/products/radiation-therapy-brain-metastases
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  5. effectivehealthcare.ahrq.gov/products/methods-quantitative-synthesis-update
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  6. effectivehealthcare.ahrq.gov/products/methods-guidance-bias/methods/41
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  7. effectivehealthcare.ahrq.gov/products/registries-guide-3rd-edition-addendum
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  8. effectivehealthcare.ahrq.gov/products/registries-guide-update
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  9. effectivehealthcare.ahrq.gov/products?fB0D=field_product_typeAresearch_report&fB1D=field_product_typeAsystematic_review&fB2D=field_product_typeAtechnical_brief&sort_by=field_product_pub_date
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  10. effectivehealthcare.ahrq.gov/products?f%B0%5D=field_product_type%3Acme_ce
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  11. effectivehealthcare.ahrq.gov/products/ptsd-repository-expanded
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  12. effectivehealthcare.ahrq.gov/products/health-systems-use-evidence/crt
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  13. effectivehealthcare.ahrq.gov/products/insulin-blood-sugar-2010/sites/default/files
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  14. effectivehealthcare.ahrq.gov/products/insulin-blood-sugar-2010/sites/default
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  15. effectivehealthcare.ahrq.gov/products/insulin-blood-sugar-2010/sites
    September 23, 2021 - White Paper March 19, 2021 Antibody Response Following SARS-CoV-2 Infection and Implications
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary.pdf
    October 01, 2021 - Implications and Conclusions A central dilemma facing interventions intended to reduce the healthcare … sort_by=field_product_pub_date Main Points Background and Purpose Methods Results Limitations Implications
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-evidence-summary.pdf
    October 01, 2021 - Implications and Conclusions A central dilemma facing interventions intended to reduce the healthcare … sort_by=field_product_pub_date Main Points Background and Purpose Methods Results Limitations Implications
  18. effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
    May 01, 2020 - No.20-EHC014-1 May 2020 4 Implications and Conclusions Compared with treatment as usual ( … sort_by=field_product_pub_date Main Points Background and Purpose Methods Results Limitations Implications
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
    January 01, 2022 - Implications and Conclusions This report updates the previous AHRQ report with comprehensive data, calculated … effectivehealthcare.ahrq.gov/products/search Main Points Background and Purpose Methods Results Limitations Implications
  20. effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
    December 01, 2020 - Implications and Conclusions High and moderate strength of evidence support the effectiveness of triptans … The lack of risk assessment tools and mitigation strategies has major implications for practical implementation … : Opioid Therapy KQ2: Nonopioid Pharmacologic Therapy KQ3: Nonpharmacologic Therapy Limitations Implications

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: